Internship
Develops and delivers biopharmaceutical medicines
$27 - $30/hr
Company Historically Provides H1B Sponsorship
Princeton, NJ, USA
Physical presence at the BMS worksite or physical presence in the field is a necessary job function of this role, which the Company deems critical to collaboration, innovation, productivity, employee well-being and engagement, and it enhances the Company culture. Applicants can request a reasonable workplace accommodation/adjustment prior to accepting a job offer.
Get referrals →
You have ways to get a Bristol Myers Squibb referral from your network.
Applications through a referral are 3x more likely to get an interview!
Upload your resume to see how it matches 12 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs that are affordable alternatives to their innovative medicines, ensuring they meet high safety and quality standards. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, along with a strong commitment to sustainability and corporate responsibility. The company's goal is to improve patient outcomes by providing effective and affordable healthcare solutions while adhering to Environmental, Social, and Governance (ESG) principles.
Company Size
10,001+
Company Stage
IPO
Headquarters
New York City, New York
Founded
1887
Help us improve and share your feedback! Did you find this helpful?
Flexible Work Hours
Hybrid Work Options
Professional Development Budget
This year alone BMS has laid off more than 800 employees, the bulk of which were just revealed this month, putting 516 jobs on the chopping block.
Bristol Myers Squibb, the fourth-largest company in New Jersey by market cap, announced Tuesday the appointment of Cari Gallman as executive vice president, general counsel and chief policy officer, effective immediately. She succeeds Sandra (Sandy) Leung, who is retiring after a 33-year career at the company.Gallman has extensive experience in pharmaceutical law and compliance. She will lead the law department, which includes intellectual property, commercial and regulatory law, litigation, securities and corporate governance, transactions, corporate security and compliance and ethics, as well as global and U.S. policy and government affairs. Gallman has held leadership positions at Bristol Myers Squibb for 10 years, most recently serving as executive vice president, corporate affairs.“I am committed to continuing to build on the company’s culture of integrity and shape a dynamic policy environment that protects innovation and patients,” said Gallman in a statement.Gallman began her legal career in private practice representing pharmaceutical and medical device manufacturers in civil, regulatory, and government enforcement matters.She earned a bachelor’s degree in political theory from Princeton University, magna cum laude, and holds a juris doctor degree from Harvard Law School
Bristol Myers to lay off over 500 workers in New Jersey.
BMS recently announced plans to close a manufacturing facility in Illinois that handles viral vector production.
BMS to lay off 516 employees at its Lawrence Township facility.